Other: 18F-Fluorodeoxyglucose (18F-FDG) PET/CT ( DrugBank: 18F-FDG )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 84 | Sarcoidosis | 1 |
84. Sarcoidosis
Clinical trials : 149 / Drugs : 227 - (DrugBank : 81) / Drug target genes : 82 - Drug target pathways : 167
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01764191 (ClinicalTrials.gov) | January 1, 2012 | 3/1/2013 | 18F-FDG PET Imaging in Cardiac Sarcoidosis | [18 F]-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography (PET) in Cardiac Sarcoidosis | Cardiac Sarcoidosis | Other: 18F-Fluorodeoxyglucose (18F-FDG) PET/CT | British Columbia Cancer Agency | NULL | Approved for marketing | 19 Years | N/A | All | Canada |